The Ras-related Protein Rheb Is Farnesylated and Antagonizes Ras Signaling and Transformation

作者：Geoffrey Clark, Michael S. Kinch, Kelley Rogers-Graham, Saı̈d M. Sebti, Andrew D. Hamilton, Channing J. Der · 发表于：Journal of Biological Chemistry · 年份：1997 · DOI：10.1074/jbc.272.16.10608 · 被引用次数：181 · 研究领域：Protein Kinase Regulation and GTPase Signaling、Melanoma and MAPK Pathways、Cancer-related Molecular Pathways

Presently, nothing is known about the function of the Ras-related protein Rheb. Since Rheb shares significant sequence identity with the core effector domains of Ras and KRev-1/Rap1A, it may share functional similarities with these two structurally related, yet functionally distinct, small GTPases. Furthermore, since like Ras, Rheb terminates with a COOH terminus that is likely to signal for farnesylation, it may be a target for the farnesyltransferase inhibitors that block Ras processing and function. To compare Rheb function with those of Ras and KRev-1, we introduced mutations into Rheb that generate constitutively active or dominant negative forms of Ras and Ras-related proteins and were designated Rheb(64L) and Rheb(20N), respectively. Expression of wild type or mutant Rheb did not alter the morphology or growth properties of NIH 3T3 cells. Thus, aberrant Rheb function is distinct from that of Ras and fails to cause cellular transformation. Instead, similar to KRev-1, co-expression of Rheb antagonized oncogenic Ras transformation and signaling. In vitro and in vivo analyses showed that like Ras, Rheb proteins are farnesylated and are sensitive to farnesyltransferase inhibition. Thus, it is possible that Rheb function may be inhibited by farnesyltransferase inhibitors treatment and, consequently, may contribute to the ability of these inhibitors to impair Ras transformation.